Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:16:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Massachusetts, New Jersey, New York, and Pennsylvania; updated the page revision to v3.3.3 and removed the HHS Vulnerability Disclosure and the individual state location entries.
    Difference
    0.5%
    Check dated 2025-12-23T22:46:46.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study content or site functionality has changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:31:22.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed the site-wide notice about a lapse in government funding and NIH operating status. The core study information on the page remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:16:35.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now includes posted results for NCT03769467, with results reporting dates and outcome measures (ORR, DoR, PFS, OS) added to the record. This updates the study record with new efficacy and safety data beyond the initial details.
    Difference
    0.4%
    Check dated 2025-11-03T21:18:15.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an operational status notice about potential delays and updated links; replaces the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:58:29.000Z thumbnail image

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.